{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:43:57Z","timestamp":1789447437026,"version":"build-2803163510"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T00:00:00Z","timestamp":1424131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s11914-015-0258-z","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T04:17:23Z","timestamp":1424146643000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["The Immunological Contribution to Heterotopic Ossification Disorders"],"prefix":"10.1007","volume":"13","author":[{"given":"Michael R.","family":"Convente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,17]]},"reference":[{"issue":"8","key":"258_CR1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1302\/2046-3758.18.2000102","volume":"1","author":"KA Alfieri","year":"2012","unstructured":"Alfieri KA, Forsberg JA, Potter BK. Blast injuries and heterotopic ossification. Bone Joint Res. 2012;1(8):192\u20137.","journal-title":"Bone Joint Res"},{"issue":"4","key":"258_CR2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/0363546511434285","volume":"40","author":"A Bedi","year":"2012","unstructured":"Bedi A, Zbeda RM, Bueno VF, et al. The incidence of heterotopic ossification after hip arthroscopy. Am J Sports Med. 2012;40(4):854\u201363.","journal-title":"Am J Sports Med"},{"issue":"11","key":"258_CR3","first-page":"E232","volume":"40","author":"RM Cohn","year":"2011","unstructured":"Cohn RM, Schwarzkopf R, Jaffe F. Heterotopic ossification after total hip arthroplasty. Am J Orthop (Belle Mead NJ). 2011;40(11):E232\u20135.","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"14","key":"258_CR4","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/ajmg.a.32346","volume":"146A","author":"NS Adegbite","year":"2008","unstructured":"Adegbite NS, Xu M, Kaplan FS, et al. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification. Am J Med Genet A. 2008;146A(14):1788\u201396.","journal-title":"Am J Med Genet A"},{"issue":"3","key":"258_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","volume":"30","author":"FS Kaplan","year":"2009","unstructured":"Kaplan FS, Xu M, Seemann P, et al. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2009;30(3):379\u201390.","journal-title":"Hum Mutat"},{"issue":"3\u20134","key":"258_CR6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1385\/BMM:3:3-4:261","volume":"3","author":"RJ Pignolo","year":"2005","unstructured":"Pignolo RJ, Foley KL. Nonhereditary heterotopic ossification: implications for injury, arthroplasty, and aging. Clin Rev Bone Miner Metab. 2005;3(3\u20134):261\u20136.","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"9","key":"258_CR7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOT.0b013e3181ed147b","volume":"24","author":"EJ Mitchell","year":"2010","unstructured":"Mitchell EJ, Canter J, Norris P, et al. The genetics of heterotopic ossification: insight into the bone remodeling pathway. J Orthop Trauma. 2010;24(9):530\u20133.","journal-title":"J Orthop Trauma"},{"issue":"5","key":"258_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2106\/JBJS.H.00792","volume":"91","author":"JA Forsberg","year":"2009","unstructured":"Forsberg JA, Pepek JM, Wagner S, et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am. 2009;91(5):1084\u201391.","journal-title":"J Bone Joint Surg Am"},{"key":"258_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.blo.0000129557.38803.26","volume":"423","author":"RF Scarlett","year":"2004","unstructured":"Scarlett RF, Rocke DM, Kantanie S, et al. Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 2004;423:275\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"258_CR10","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/jcb.23225","volume":"112","author":"E Salisbury","year":"2011","unstructured":"Salisbury E, Rodenberg E, Sonnet C, et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem. 2011;112(10):2748\u201358.","journal-title":"J Cell Biochem"},{"issue":"12","key":"258_CR11","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm.1888","volume":"14","author":"PB Yu","year":"2008","unstructured":"Yu PB, Deng DY, Lai CS, et al. BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med. 2008;14(12):1363\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"258_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bone.2013.03.020","volume":"55","author":"P Hoff","year":"2013","unstructured":"Hoff P, Rakow A, Gaber T, et al. Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans. Bone. 2013;55(1):93\u2013101.","journal-title":"Bone"},{"issue":"11","key":"258_CR13","doi-asserted-by":"crossref","first-page":"e204","DOI":"10.1097\/BOT.0b013e31825d60a5","volume":"26","author":"KN Evans","year":"2012","unstructured":"Evans KN, Forsberg JA, Potter BK, et al. Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. J Orthop Trauma. 2012;26(11):e204\u201313.","journal-title":"J Orthop Trauma"},{"issue":"3\u20134","key":"258_CR14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/BMM:3:3-4:189","volume":"3","author":"FS Kaplan","year":"2005","unstructured":"Kaplan FS, Shore EM, Gupta R, et al. Immunological features of fibrodysplasia ossificans progressiva and the dysregulated BMP4 pathway. Clin Rev Bone Miner Metab. 2005;3(3\u20134):189\u201393.","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"9","key":"258_CR15","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s11999-014-3694-7","volume":"472","author":"JA Forsberg","year":"2014","unstructured":"Forsberg JA, Potter BK, Polfer EM, et al. Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds? Clin Orthop Relat Res. 2014;472(9):2845\u201354.","journal-title":"Clin Orthop Relat Res"},{"issue":"5 Pt 1","key":"258_CR16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(95)70408-6","volume":"126","author":"TF Lanchoney","year":"1995","unstructured":"Lanchoney TF, Cohen RB, Rocke DM, et al. Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva. J Pediatr. 1995;126(5 Pt 1):762\u20134.","journal-title":"J Pediatr"},{"issue":"9","key":"258_CR17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","volume":"6","author":"EM Shore","year":"2010","unstructured":"Shore EM, Kaplan FS. Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol. 2010;6(9):518\u201327.","journal-title":"Nat Rev Rheumatol"},{"key":"258_CR18","doi-asserted-by":"crossref","unstructured":"Shore EM, Ahn J, Jan de Beur S, et al. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med. 2002;346(2):99\u2013106.","DOI":"10.1056\/NEJMoa011262"},{"issue":"5","key":"258_CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM, Xu M, Feldman GJ, et al. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006;38(5):525\u20137.","journal-title":"Nat Genet"},{"issue":"6812","key":"258_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/35046196","volume":"408","author":"JR Arron","year":"2000","unstructured":"Arron JR, Choi Y. Bone versus immune system. Nature. 2000;408(6812):535\u20136.","journal-title":"Nature"},{"issue":"7","key":"258_CR21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/jbmr.354","volume":"26","author":"KA Alexander","year":"2011","unstructured":"Alexander KA, Chang MK, Maylin ER, et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011;26(7):1517\u201332.","journal-title":"J Bone Miner Res"},{"issue":"11","key":"258_CR22","doi-asserted-by":"crossref","first-page":"e81341","DOI":"10.1371\/journal.pone.0081341","volume":"8","author":"C Ehrnthaller","year":"2013","unstructured":"Ehrnthaller C, Huber-Lang M, Nilsson P, et al. Complement C3 and C5 deficiency affects fracture healing. PLoS One. 2013;8(11):e81341.","journal-title":"PLoS One"},{"issue":"1","key":"258_CR23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.smim.2013.05.006","volume":"25","author":"M Huber-Lang","year":"2013","unstructured":"Huber-Lang M, Kovtun A, Ignatius A. The role of complement in trauma and fracture healing. Semin Immunol. 2013;25(1):73\u20138.","journal-title":"Semin Immunol"},{"key":"258_CR24","unstructured":"Wu AC, Raggatt LJ, Alexander KA, et al. Unraveling macrophage contributions to bone repair. Bonekey Rep. 2013;2:373."},{"issue":"1","key":"258_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-014-0195-2","volume":"12","author":"JF Charles","year":"2014","unstructured":"Charles JF, Nakamura MC. Bone and the innate immune system. Curr Osteoporos Rep. 2014;12(1):1\u20138.","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"258_CR26","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1002\/art.22175","volume":"54","author":"F Benedetti De","year":"2006","unstructured":"De Benedetti F, Rucci N, Del Fattore A, et al. Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum. 2006;54(11):3551\u201363.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"258_CR27","doi-asserted-by":"crossref","first-page":"e35979","DOI":"10.1371\/journal.pone.0035979","volume":"7","author":"SL Bonar","year":"2012","unstructured":"Bonar SL, Brydges SD, Mueller JL, et al. Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One. 2012;7(4):e35979.","journal-title":"PLoS One"},{"issue":"3","key":"258_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","volume":"201","author":"R Hardy","year":"2009","unstructured":"Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol. 2009;201(3):309\u201320.","journal-title":"J Endocrinol"},{"issue":"2","key":"258_CR29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","volume":"22","author":"TH Mogensen","year":"2009","unstructured":"Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 2009;22(2):240\u201373. Table of Contents.","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"258_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nri2944","volume":"11","author":"T Boehm","year":"2011","unstructured":"Boehm T. Design principles of adaptive immune systems. Nat Rev Immunol. 2011;11(5):307\u201317.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"258_CR31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.bbadis.2012.09.014","volume":"1832","author":"LA Borthwick","year":"2013","unstructured":"Borthwick LA, Wynn TA, Fisher AJ. Cytokine mediated tissue fibrosis. Biochim Biophys Acta. 2013;1832(7):1049\u201360.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"258_CR32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.4049\/jimmunol.180.1.569","volume":"180","author":"Y Ishida","year":"2007","unstructured":"Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol. 2007;180(1):569\u201379.","journal-title":"J Immunol"},{"issue":"2","key":"258_CR33","doi-asserted-by":"crossref","first-page":"R345","DOI":"10.1152\/ajpregu.00454.2004","volume":"288","author":"JG Tidball","year":"2005","unstructured":"Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288(2):R345\u201353.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"258_CR34","doi-asserted-by":"crossref","unstructured":"Kan L, Lounev VY, Pignolo RJ, et al. Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem. 2011;112(10):2759\u201372. This study is the first to show that chemical inhibition of mast cells and Substance P signaling significantly reduces HO formation in vivo and provides a link between elevated Substance P levels in FOP patients and HO development.","DOI":"10.1002\/jcb.23259"},{"key":"258_CR35","doi-asserted-by":"crossref","unstructured":"Kan L, Mutso AA, McGuire TL, et al. Opioid signaling in mast cells regulates injury responses associated with heterotopic ossification. Inflamm Res. 2014;63(3):207\u201315. This study further elucidated the role of mast cells and their signaling pathways in the development of HO.","DOI":"10.1007\/s00011-013-0690-4"},{"issue":"1","key":"258_CR36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1634\/stemcells.2008-0576","volume":"27","author":"L Kan","year":"2009","unstructured":"Kan L, Liu Y, McGuire TL, et al. Dysregulation of local stem\/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells. 2009;27(1):150\u20136.","journal-title":"Stem Cells"},{"issue":"1","key":"258_CR37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S8756-3282(01)00638-X","volume":"30","author":"CM Champagne","year":"2002","unstructured":"Champagne CM, Takebe J, Offenbacher S, et al. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone. 2002;30(1):26\u201331.","journal-title":"Bone"},{"issue":"12","key":"258_CR38","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8(12):958\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"258_CR39","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/01.CIR.103.11.1522","volume":"103","author":"ER Mohler","year":"2001","unstructured":"Mohler ER, Gannon F, Reynolds C, et al. Bone formation and inflammation in cardiac valves. Circulation. 2001;103(11):1522\u20138.","journal-title":"Circulation"},{"issue":"8","key":"258_CR40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/hupa.2001.26464","volume":"32","author":"FH Gannon","year":"2001","unstructured":"Gannon FH, Glaser D, Caron R, et al. Mast cell involvement in fibrodysplasia ossificans progressiva. Hum Pathol. 2001;32(8):842\u20138.","journal-title":"Hum Pathol"},{"issue":"5","key":"258_CR41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/089686080402400513","volume":"24","author":"N Paolo Di","year":"2004","unstructured":"Di Paolo N, Sacchi G, Lorenzoni P, et al. Ossification of the peritoneal membrane. Perit Dial Int. 2004;24(5):471\u20137.","journal-title":"Perit Dial Int"},{"issue":"2","key":"258_CR42","first-page":"317","volume":"151","author":"RS Smith","year":"1997","unstructured":"Smith RS, Smith TJ, Blieden TM, et al. Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 1997;151(2):317\u201322.","journal-title":"Am J Pathol"},{"issue":"9","key":"258_CR43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785\u201397.","journal-title":"Nat Immunol"},{"issue":"9","key":"258_CR44","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/jcb.23186","volume":"112","author":"A Ignatius","year":"2011","unstructured":"Ignatius A, Schoengraf P, Kreja L, et al. Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1beta. J Cell Biochem. 2011;112(9):2594\u2013605.","journal-title":"J Cell Biochem"},{"issue":"9","key":"258_CR45","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2169\/internalmedicine.42.834","volume":"42","author":"T Tsuji","year":"2003","unstructured":"Tsuji T, Nakamura S, Komuro I, et al. A living case of pulmonary ossification associated with osteoclast formation from alveolar macrophage in the presence of T-cell cytokines. Intern Med. 2003;42(9):834\u20138.","journal-title":"Intern Med"},{"key":"258_CR46","doi-asserted-by":"crossref","unstructured":"Chakkalakal SA, Zhang D, Culbert AL, et al. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res. 2012;27(8):1746\u201356. The first publication of an Alk2 (R206H) knock-in mouse model of HO, resulting in very strong recapitulation of the human disease.","DOI":"10.1002\/jbmr.1637"},{"issue":"1","key":"258_CR47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.1413","volume":"201","author":"L Hegyi","year":"2003","unstructured":"Hegyi L, Gannon FH, Glaser DL, et al. Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2\/Cbfa-1: clues to a vascular origin of heterotopic ossification? J Pathol. 2003;201(1):141\u20138.","journal-title":"J Pathol"},{"issue":"4","key":"258_CR48","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0002-9440(10)63372-X","volume":"165","author":"L Kan","year":"2004","unstructured":"Kan L, Hu M, Gomes WA, et al. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol. 2004;165(4):1107\u201315.","journal-title":"Am J Pathol"},{"issue":"6","key":"258_CR49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","volume":"32","author":"CD Mills","year":"2012","unstructured":"Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol. 2012;32(6):463\u201388.","journal-title":"Crit Rev Immunol"},{"issue":"2","key":"258_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nri2018","volume":"7","author":"SC Bischoff","year":"2007","unstructured":"Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol. 2007;7(2):93\u2013104.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"258_CR51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-012-0322-z","volume":"13","author":"M Frieri","year":"2013","unstructured":"Frieri M, Patel R, Celestin J. Mast cell activation syndrome: a review. Curr Allergy Asthma Rep. 2013;13(1):27\u201332.","journal-title":"Curr Allergy Asthma Rep"},{"key":"258_CR52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-800267-4.00006-7","volume":"122","author":"J Douaiher","year":"2014","unstructured":"Douaiher J, Succar J, Lancerotto L, et al. Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol. 2014;122:211\u201352.","journal-title":"Adv Immunol"},{"issue":"4","key":"258_CR53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/wound.2012.0414","volume":"2","author":"HP Ehrlich","year":"2013","unstructured":"Ehrlich HP. A snapshot of direct cell-cell communications in wound healing and scarring. Adv Wound Care (New Rochelle). 2013;2(4):113\u201321.","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"258_CR54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2012.07.007","volume":"37","author":"HR Rodewald","year":"2012","unstructured":"Rodewald HR, Feyerabend TB. Widespread immunological functions of mast cells: fact or fiction? Immunity. 2012;37(1):13\u201324.","journal-title":"Immunity"},{"issue":"11","key":"258_CR55","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood-2013-04-498105","volume":"122","author":"L Vincent","year":"2013","unstructured":"Vincent L, Vang D, Nguyen J, et al. Mast cell activation contributes to sickle cell pathobiology and pain in mice. Blood. 2013;122(11):1853\u201362.","journal-title":"Blood"},{"key":"258_CR56","doi-asserted-by":"crossref","unstructured":"Oldford SA, Marshall JS. Mast cells as targets for immunotherapy of solid tumors. Mol Immunol. 2014.","DOI":"10.1016\/j.molimm.2014.02.020"},{"issue":"1\u20132","key":"258_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2013.09.018","volume":"264","author":"A Heron","year":"2013","unstructured":"Heron A, Dubayle D. A focus on mast cells and pain. J Neuroimmunol. 2013;264(1\u20132):1\u20137.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"258_CR58","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biomaterials.2013.10.068","volume":"35","author":"BL Farrugia","year":"2014","unstructured":"Farrugia BL, Whitelock JM, Jung M, et al. The localisation of inflammatory cells and expression of associated proteoglycans in response to implanted chitosan. Biomaterials. 2014;35(5):1462\u201377.","journal-title":"Biomaterials"},{"issue":"33","key":"258_CR59","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.1016\/j.biomaterials.2011.07.084","volume":"32","author":"PT Thevenot","year":"2011","unstructured":"Thevenot PT, Baker DW, Weng H, et al. The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials. Biomaterials. 2011;32(33):8394\u2013403.","journal-title":"Biomaterials"},{"issue":"6","key":"258_CR60","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nri2327","volume":"8","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol. 2008;8(6):478\u201386.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"258_CR61","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","volume":"9","author":"J Kalesnikoff","year":"2008","unstructured":"Kalesnikoff J, Galli SJ. New developments in mast cell biology. Nat Immunol. 2008;9(11):1215\u201323.","journal-title":"Nat Immunol"},{"key":"258_CR62","first-page":"120","volume":"3","author":"G Gri","year":"2012","unstructured":"Gri G, Frossi B, D\u2019Inca F, et al. Mast cell: an emerging partner in immune interaction. Front Immunol. 2012;3:120.","journal-title":"Front Immunol"},{"issue":"3","key":"258_CR63","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1124\/jpet.107.132795","volume":"324","author":"RC Bucelli","year":"2008","unstructured":"Bucelli RC, Gonsiorek EA, Kim WY, et al. Statins decrease expression of the proinflammatory neuropeptides calcitonin gene-related peptide and substance P in sensory neurons. J Pharmacol Exp Ther. 2008;324(3):1172\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"258_CR64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i4.30","volume":"20","author":"E Salisbury","year":"2010","unstructured":"Salisbury E, Sonnet C, Heggeness M, et al. Heterotopic ossification has some nerve. Crit Rev Eukaryot Gene Expr. 2010;20(4):313\u201324.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"258_CR65","first-page":"174","volume":"4","author":"C Overed-Sayer","year":"2013","unstructured":"Overed-Sayer C, Rapley L, Mustelin T, et al. Are mast cells instrumental for fibrotic diseases? Front Pharmacol. 2013;4:174.","journal-title":"Front Pharmacol"},{"issue":"4","key":"258_CR66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00011-011-0409-3","volume":"61","author":"MJ Monument","year":"2012","unstructured":"Monument MJ, Hart DA, Befus AD, et al. The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures. Inflamm Res. 2012;61(4):285\u201392.","journal-title":"Inflamm Res"},{"issue":"8","key":"258_CR67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nri2807","volume":"10","author":"GW Litman","year":"2010","unstructured":"Litman GW, Rast JP, Fugmann SD. The origins of vertebrate adaptive immunity. Nat Rev Immunol. 2010;10(8):543\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"258_CR68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-7364-5-1-30","volume":"5","author":"C Brocker","year":"2010","unstructured":"Brocker C, Thompson D, Matsumoto A, et al. Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics. 2010;5(1):30\u201355.","journal-title":"Hum Genomics"},{"issue":"1","key":"258_CR69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.6","volume":"35","author":"V Fensterl","year":"2009","unstructured":"Fensterl V, Sen GC. Interferons and viral infections. Biofactors. 2009;35(1):14\u201320.","journal-title":"Biofactors"},{"key":"258_CR70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-199801000-00005","volume":"346","author":"FH Gannon","year":"1998","unstructured":"Gannon FH, Valentine BA, Shore EM, et al. Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res. 1998;346:19\u201325.","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"258_CR71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2106\/JBJS.F.00472","volume":"89","author":"FS Kaplan","year":"2007","unstructured":"Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am. 2007;89(2):347\u201357.","journal-title":"J Bone Joint Surg Am"},{"issue":"12","key":"258_CR72","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1161\/ATVBAHA.111.234724","volume":"31","author":"KP Egan","year":"2011","unstructured":"Egan KP, Kim JH, Mohler 3rd ER, et al. Role for circulating osteogenic precursor cells in aortic valvular disease. Arterioscler Thromb Vasc Biol. 2011;31(12):2965\u201371.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"258_CR73","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/jcb.20933","volume":"98","author":"L Rifas","year":"2006","unstructured":"Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem. 2006;98(4):706\u201314.","journal-title":"J Cell Biochem"},{"issue":"9","key":"258_CR74","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1073\/pnas.91.9.3652","volume":"91","author":"MW Carr","year":"1994","unstructured":"Carr MW, Roth SJ, Luther E, et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A. 1994;91(9):3652\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"258_CR75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313\u201326.","journal-title":"J Interferon Cytokine Res"},{"issue":"3","key":"258_CR76","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.stem.2009.02.001","volume":"4","author":"JM Karp","year":"2009","unstructured":"Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009;4(3):206\u201316.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"258_CR77","doi-asserted-by":"crossref","first-page":"e2934","DOI":"10.1371\/journal.pone.0002934","volume":"3","author":"G Chamberlain","year":"2008","unstructured":"Chamberlain G, Wright K, Rot A, et al. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One. 2008;3(8):e2934.","journal-title":"PLoS One"},{"issue":"2","key":"258_CR78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2004-09-3507","volume":"106","author":"V Sordi","year":"2005","unstructured":"Sordi V, Malosio ML, Marchesi F, et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood. 2005;106(2):419\u201327.","journal-title":"Blood"},{"issue":"2","key":"258_CR79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199\u2013210.","journal-title":"J Pathol"},{"issue":"6","key":"258_CR80","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.173.6.4020","volume":"173","author":"M Kaviratne","year":"2004","unstructured":"Kaviratne M, Hesse M, Leusink M, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-independent. J Immunol. 2004;173(6):4020\u20139.","journal-title":"J Immunol"},{"key":"258_CR81","doi-asserted-by":"crossref","unstructured":"Culbert AL, Chakkalakal SA, Theosmy EG, et al. Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells. 2014;32(5):1289\u2013300. This study utilized in vitro and in vivo approaches to demonstrate the molecular role of Alk2 in the chondrogenesis stage of HO in FOP.","DOI":"10.1002\/stem.1633"},{"key":"258_CR82","doi-asserted-by":"crossref","unstructured":"Akdis M, Burgler S, Crameri R, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127(3):701\u201321. e1-70.","DOI":"10.1016\/j.jaci.2010.11.050"},{"issue":"12","key":"258_CR83","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1182\/blood-2003-05-1657","volume":"102","author":"PT Tsai","year":"2003","unstructured":"Tsai PT, Lee RA, Wu H. BMP4 acts upstream of FGF in modulating thymic stroma and regulating thymopoiesis. Blood. 2003;102(12):3947\u201353.","journal-title":"Blood"},{"issue":"5\u20136","key":"258_CR84","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1006\/bcmd.1999.0259","volume":"25","author":"K Detmer","year":"1999","unstructured":"Detmer K, Steele TA, Shoop MA, et al. Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines. Blood Cells Mol Dis. 1999;25(5\u20136):310\u201323.","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"258_CR85","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/eji.200636759","volume":"37","author":"EA Sivertsen","year":"2007","unstructured":"Sivertsen EA, Huse K, Hystad ME, et al. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur J Immunol. 2007;37(10):2937\u201348.","journal-title":"Eur J Immunol"},{"issue":"2","key":"258_CR86","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/BPO.0b013e3181cec35b","volume":"30","author":"KM MacDonald","year":"2010","unstructured":"MacDonald KM, Swanstrom MM, McCarthy JJ, et al. Exaggerated inflammatory response after use of recombinant bone morphogenetic protein in recurrent unicameral bone cysts. J Pediatr Orthop. 2010;30(2):199\u2013205.","journal-title":"J Pediatr Orthop"},{"issue":"24","key":"258_CR87","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.1073\/pnas.89.24.11740","volume":"89","author":"NS Cunningham","year":"1992","unstructured":"Cunningham NS, Paralkar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A. 1992;89(24):11740\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"258_CR88","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00774-008-0879-8","volume":"26","author":"FS Kaplan","year":"2008","unstructured":"Kaplan FS, Shen Q, Lounev V, et al. Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab. 2008;26(6):521\u201330.","journal-title":"J Bone Miner Metab"},{"key":"258_CR89","doi-asserted-by":"crossref","unstructured":"Shimono K, Tung WE, Macolino C, et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists. Nat Med. 2011;17(4):454\u201360. This study documents potent in vivo inhibition of HO by administration with retinoic acid receptor-gamma agonists, identifying a new potential therapeutic target for the treatment of HO disorders.","DOI":"10.1038\/nm.2334"},{"issue":"12","key":"258_CR90","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s11999-009-0924-5","volume":"467","author":"P Vavken","year":"2009","unstructured":"Vavken P, Castellani L, Sculco TP. Prophylaxis of heterotopic ossification of the hip: systematic review and meta-analysis. Clin Orthop Relat Res. 2009;467(12):3283\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"258_CR91","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(97)00147-6","volume":"21","author":"WS Jee","year":"1997","unstructured":"Jee WS, Ma YF. The in vivo anabolic actions of prostaglandins in bone. Bone. 1997;21(4):297\u2013304.","journal-title":"Bone"},{"issue":"1","key":"258_CR92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17453670610013484","volume":"78","author":"JG Grohs","year":"2007","unstructured":"Grohs JG, Schmidt M, Wanivenhaus A. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up. Acta Orthop. 2007;78(1):95\u20138.","journal-title":"Acta Orthop"},{"issue":"1","key":"258_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(89)90178-6","volume":"124","author":"N Rooijen Van","year":"1989","unstructured":"Van Rooijen N. The liposome-mediated macrophage \u2018suicide\u2019 technique. J Immunol Methods. 1989;124(1):1\u20136.","journal-title":"J Immunol Methods"},{"issue":"8","key":"258_CR94","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ki.2012.207","volume":"82","author":"DA Ferenbach","year":"2012","unstructured":"Ferenbach DA, Sheldrake TA, Dhaliwal K, et al. Macrophage\/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia\/reperfusion injury in mice. Kidney Int. 2012;82(8):928\u201333.","journal-title":"Kidney Int"},{"issue":"6","key":"258_CR95","doi-asserted-by":"crossref","first-page":"R1488","DOI":"10.1152\/ajpregu.00465.2005","volume":"290","author":"M Summan","year":"2006","unstructured":"Summan M, Warren GL, Mercer RR, et al. Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol. 2006;290(6):R1488\u201395.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"258_CR96","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.510230544","volume":"23","author":"N Rooijen Van","year":"1996","unstructured":"Van Rooijen N, Sanders A. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid. Hepatology. 1996;23(5):1239\u201343.","journal-title":"Hepatology"},{"issue":"9","key":"258_CR97","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K","volume":"43","author":"P Barrera","year":"2000","unstructured":"Barrera P, Blom A, van Lent PL, et al. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 2000;43(9):1951\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"258_CR98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"TM O\u2019Connor","year":"2004","unstructured":"O\u2019Connor TM, O\u2019Connell J, O\u2019Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201(2):167\u201380.","journal-title":"J Cell Physiol"},{"issue":"18","key":"258_CR99","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1097\/QAD.0b013e3283405c33","volume":"24","author":"MM Manak","year":"2010","unstructured":"Manak MM, Moshkoff DA, Nguyen LT, et al. Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals. AIDS. 2010;24(18):2789\u201396.","journal-title":"AIDS"},{"issue":"8","key":"258_CR100","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/ard.2004.029835","volume":"64","author":"A Juurikivi","year":"2005","unstructured":"Juurikivi A, Sandler C, Lindstedt KA, et al. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis. Ann Rheum Dis. 2005;64(8):1126\u201331.","journal-title":"Ann Rheum Dis"},{"key":"258_CR101","doi-asserted-by":"crossref","unstructured":"Werner CM, Zimmermann SM, Wurgler-Hauri CC, et al. Use of imatinib in the prevention of heterotopic ossification. HSS J. 2013;9(2):166\u201370. Administration of imatinib, resulting in blockage of PDGF signaling, reduced HO volume by 85% in an Achilles tenotomy mouse model of HO, documenting an additional approach by which to therapeutically intervene in cases of HO.","DOI":"10.1007\/s11420-013-9335-y"},{"issue":"4","key":"258_CR102","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrd3974","volume":"12","author":"JG Sathish","year":"2013","unstructured":"Sathish JG, Sethu S, Bielsky MC, et al. Challenges and approaches for the development of safer immunomodulatory biologics. Nat Rev Drug Discov. 2013;12(4):306\u201324.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"258_CR103","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","volume":"179","author":"J Zalevsky","year":"2007","unstructured":"Zalevsky J, Secher T, Ezhevsky SA, et al. Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection. J Immunol. 2007;179(3):1872\u201383.","journal-title":"J Immunol"},{"issue":"2","key":"258_CR104","doi-asserted-by":"crossref","first-page":"ii70","DOI":"10.1136\/ard.61.suppl_2.ii70","volume":"61","author":"R Rau","year":"2002","unstructured":"Rau R. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials. Ann Rheum Dis. 2002;61(2):ii70\u20133.","journal-title":"Ann Rheum Dis"},{"key":"258_CR105","doi-asserted-by":"crossref","unstructured":"Mohedas A, Wang Y, Sanvitale CE, et al. Structure-activity relationship of 3,5-diaryl-2-aminopyridine ALK2 inhibitors reveals unaltered binding affinity for fibrodysplasia ossificans progressiva causing mutants. J Med Chem. 2014.","DOI":"10.1021\/jm501177w"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-015-0258-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-015-0258-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-015-0258-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T21:52:35Z","timestamp":1598737955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-015-0258-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,17]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1007\/s11914-015-0258-z","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,17]]}}}